Patent details

Basic Information

Publication number:

EP1455781

PCT Application Number:

PCT/GB/2002/005554

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP027833052

PCT Publication Number:

WO/2003/053438

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF ANASTROZOLE FOR THE TREATMENT OF POST-MENOPAUSAL WOMEN HAVING EARLY BREAST CANCER

French Title of Invention:

UTILISATION DE L'ANASTROZOLE POUR LE TRAITEMENT DU CANCER DU SEIN A UN STADE PRECOCE CHEZ LES FEMMES MENOPAUSEES

German Title of Invention:

VERWENDUNG VON ANASTROZOL ZUR BEHANDLUNG VON POSTMENOPAUSALEN FRAUEN MIT FRÜHZEITIGEM BRUSTKREBS

SPC Number:

Dates

Filing date:

06/12/2002

Grant date:

27/08/2008

EP Publication Date:

27/08/2008

PCT Publication Date:

03/07/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/09/2004

EP B1 Publication Date:

27/08/2008

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

06/12/2022

Renunciation date:

Revocation date:

03/06/2015

Annulment date:

Owner

From:

06/12/2002

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

VAN MALDEREN MICHEL

From:

29/10/2008

Address:

ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PLOURDE Paul

Address:

United States (US)

2

Name:

VOSE Brent

Address:

United Kingdom (GB)

3

Name:

DUKES Michael

Address:

United Kingdom (GB)

4

Name:

ROGERS Anthony

Address:

United States (US)

Priority

Priority Number:

0129457

Priority Date:

10/12/2001

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

A61K 31/4196;

Filing date	Document type	Number of pages